Product Information
ASPIRIN-DIPYRIDAM ER 25-200 MG is a generic product labeled by Endo USA Inc., priced at $0.5727 per EA under NDC 49884000702. Its NADAC has been published 390 times since Jan 9, 2019.
Strength
25; 200 mg/1; mg/1
Manufacturer
Endo USA Inc.NDC
49884000702
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ASPIRIN; DIPYRIDAMOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207944On Market Since
1/30/2017
Pharmacological Classes
Price Statistics
The NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has been published 390 times since Jan 9, 2019, and over the history we have for it it has declined 86.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5727 per EA |
|---|---|
| All-time high | $4.4460 (Feb 13, 2019) |
| All-time low | $0.5561 (Mar 18, 2026) |
| 52-week high | $0.6072 |
| 52-week low | $0.5561 |
| Median price | $0.8069 |
| Average price | $1.3016 |
| Largest weekly change | +44.2% (Apr 21, 2021) |
| Weeks tracked | 390 |
| Tracking since | Jan 9, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ASPIRIN-DIPYRIDAM ER 25-200 MG?
The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN-DIPYRIDAM ER 25-200 MG, manufactured by Endo USA Inc., is $0.5727 per EA (NDC 49884000702), effective Jun 24, 2026.
How has the price of ASPIRIN-DIPYRIDAM ER 25-200 MG changed over time?
Over the history we have for it, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has declined 86.8%. It has been tracked across 390 weekly CMS publications since Jan 9, 2019.
What are the highest and lowest recorded NADAC prices for ASPIRIN-DIPYRIDAM ER 25-200 MG?
Since Jan 9, 2019, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has ranged from a low of $0.5561 (Mar 18, 2026) to a high of $4.4460 (Feb 13, 2019), with a median of $0.8069 per EA.
Are there cheaper alternatives to ASPIRIN-DIPYRIDAM ER 25-200 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ASPIRIN-DIPYRIDAM ER 25-200 MG, but none are currently priced below it.
Who manufactures ASPIRIN-DIPYRIDAM ER 25-200 MG?
ASPIRIN-DIPYRIDAM ER 25-200 MG (NDC 49884000702) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification